Akums Drugs and Pharmaceuticals informs about updates

16 Dec 2025 Evaluate

Akums Drugs and Pharmaceuticals has informed that Maxcure Nutravedics, a wholly-owned subsidiary of Akums Drugs & Pharmaceuticals, has received another order from the Office of the Deputy Commissioner of State Tax, Gujarat, imposing an additional penalty of INR 1,79,55,000/- under Section 129(3) of the CGST Act, 2017, over and above the penalty already disclosed on 15th December, 2025. Details required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with the SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 are provided herein as Annexure-A.

The above information is a part of company’s filings submitted to BSE.

Akums Drugs & Pharma Share Price

437.30 -6.65 (-1.50%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×